26th of May 2021
Sharkawy & Sarhan advised IFC on its USD 45 million debt financing package to IDH
Keywords: Financial Institutions
Sharkawy & Sarhan is honored to have advised IFC on its USD 45 million debt financing package to IDH to expand access to high-quality diagnostic services across new and existing markets. The eight-year loan will be used to finance IDH’s growth plans across new and existing markets and help expand access to high-quality diagnostic services in high-growth emerging markets, in addition to its current presence in Egypt, Jordan, Nigeria, and Sudan.
Sharkawy & Sarhan is honored to have advised IFC on its USD 45 million debt financing package to IDH to expand access to high-quality diagnostic services across new and existing markets. The eight-year loan will be used to finance IDH’s growth plans across new and existing markets and help expand access to high-quality diagnostic services in high-growth emerging markets, in addition to its current presence in Egypt, Jordan, Nigeria, and Sudan.

Sharkawy & Sarhan advised IFC on its USD 45 million debt financing package to IDH
26th of May 2021
Keywords: Financial Institutions
Sharkawy & Sarhan is honored to have advised IFC on its USD 45 million debt financing package to IDH to expand access to high-quality diagnostic services across new and existing markets. The eight-year loan will be used to finance IDH’s growth plans across new and existing markets and help expand access to high-quality diagnostic services in high-growth emerging markets, in addition to its current presence in Egypt, Jordan, Nigeria, and Sudan.
Sharkawy & Sarhan is honored to have advised IFC on its USD 45 million debt financing package to IDH to expand access to high-quality diagnostic services across new and existing markets. The eight-year loan will be used to finance IDH’s growth plans across new and existing markets and help expand access to high-quality diagnostic services in high-growth emerging markets, in addition to its current presence in Egypt, Jordan, Nigeria, and Sudan.